EDGAR Filing Documents for 0000897069-05-000652

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0000897069-05-000652

Filing Date

2005-03-15

Accepted

2005-03-15 12:56:23

Documents

Period of Report

2004-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	REPORT OF FOREIGN ISSUER	sdc944.htm	6-K	818118
2	GRAPHIC	kpmg.jpg	GRAPHIC	3171
3	GRAPHIC	kpmg2.jpg	GRAPHIC	2172
	Complete submission text file	0000897069-05-000652.txt		825241

Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2

Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32

NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 05680899
SIC: 2835 In Vitro & In Vivo Diagnostic Substances